跳至主要内容
临床试验/NCT07373730
NCT07373730已完成不适用

Clinical and Radiographic Evaluation of the Efficacy of Injectable Platelet Rich Fibrin Mixed With Hyaluronic Acid in Treatment of Temporomandibular Joint Internal Derangement: A Randomized Controlled Trial

Suez Canal University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年8月10日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
1
主要终点
Maximum mouth opening

研究概览

简要总结

we inject I-PRF and Hyaluronic Acid inside the human TMJ with internal derangement after arthrocentesis, and follow-up is made to evaluate the effect of this treatment.

详细描述

This study was made to evaluate the efficacy of injectable Platelet Rich Fibrin (I-PRF) with Hyaluronic Acid (HA) injection after arthrocentesis in treatment of Temporomandibular joint Internal Derangement.

The study was conducted on 30 patients whose ages ranged from 18 to 40 years, presented with impaired jaw function, limited mouth opening, Pain during joint movement and clicking. TMJ internal derangement was verified by preoperative MRI.

Patients with MPDS only, systemic debilitating disease, previous surgery in the TMJ, previous arthrocentesis, previous trauma to the joint were excluded from the study.

Control group: 15 cases were treated by arthrocentesis then injection of 1ml of Hyaluronic acid (HA).

Study group: 15 cases were treated by arthrocentesis then injection of 0.5ml of Hyaluronic acid (HA) and 0.5ml of injectable platelet rich fibrin (I-PRF).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • patients aged from 18 to 40 years old.
  • patients diagnosed with internal derangement of TMJ, suffering from limited mandibular movements, joint pain and clicking.
  • Patients who are free from any systemic disease (ASA I).

排除标准

  • Patients who have myofascial pain dysfunction syndrome only.
  • Patients who have previous surgery in TMJ.
  • Patients who have previous arthrocentesis within 1 year.
  • Patients with prosthetic joint replacement.
  • Patients allergic to any components of the injecting solution.
  • Patients who received previous trauma to the joint.

研究组 & 干预措施

study group

Active Comparator

干预措施: Hyalgan 20 mg in 2 ML Prefilled Syringe (Drug)

study group

Active Comparator

干预措施: I-PRF (Other)

control group

Active Comparator

干预措施: Hyalgan 20 mg in 2 ML Prefilled Syringe (Drug)

结局指标

主要结局

Maximum mouth opening

时间窗: immediate preoperative then 1, 3 and 6 months postoperatively

was measured in millimeters using a ruler or digital caliper. It is the vertical distance between the incisal edges of upper and lower central incisors at maximum opening while the patients were instructed to set in an upright position in a dental chair.

Lateral to Right movement

时间窗: immediate preoperative then 1, 3 and 6 months postoperatively

was measured in millimeters using a ruler or digital caliper. It is the horizontal distance between the maxillary and the mandibular midlines with the teeth slightly separated and the mandible moved towards the right side.

Lateral to Left movement

时间窗: immediate preoperative then 1, 3 and 6 months postoperatively

was measured in millimeters using a ruler or digital caliper. It is the horizontal distance between the maxillary and the mandibular midline with the teeth slightly separated and the mandible moved towards the left side.

Protrusive movement

时间窗: immediate preoperative then 1, 3 and 6 months postoperatively

was measured in millimeters using a ruler or digital caliper. It is the distance from midpoint of incisal edge of maxillary incisors to midpoint of incisal edge of the mandibular incisors during mandibular protrusion.

Joint Clicking

时间窗: immediate preoperative then 1, 3 and 6 months postoperatively

was measured in terms as present or absent by hearing and palpation over each joint during opening and closing jaw movements.

Joint Pain

时间窗: immediate preoperative then 1, 3 and 6 months postoperatively

was measured in a score from 0 to 10 using the visual analogue scale \[VAS\] over the TMJ area. \[ 0 is given when there is no pain, 1-3 mild pain, 4-6 moderate pain, 7-9 severe pain, 10 the worst pain\].

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验